- Home
- AXDX vs TURN Comparison
AXDX vs TURN Comparison
Compare AXDX & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXDX
- TURN
- Stock Information
- Founded
- AXDX 1982
- TURN 1981
- Country
- AXDX United States
- TURN United States
- Employees
- AXDX N/A
- TURN N/A
- Industry
- AXDX Biotechnology: Laboratory Analytical Instruments
- TURN Finance/Investors Services
- Sector
- AXDX Industrials
- TURN Finance
- Exchange
- AXDX Nasdaq
- TURN Nasdaq
- Market Cap
- AXDX 41.8M
- TURN 35.7M
- IPO Year
- AXDX 1996
- TURN N/A
- Fundamental
- Price
- AXDX $1.20
- TURN $3.65
- Analyst Decision
- AXDX Hold
- TURN
- Analyst Count
- AXDX 1
- TURN 0
- Target Price
- AXDX $1.00
- TURN N/A
- AVG Volume (30 Days)
- AXDX 63.7K
- TURN 37.2K
- Earning Date
- AXDX 11-07-2024
- TURN 08-19-2024
- Dividend Yield
- AXDX N/A
- TURN N/A
- EPS Growth
- AXDX N/A
- TURN N/A
- EPS
- AXDX N/A
- TURN N/A
- Revenue
- AXDX $11,909,000.00
- TURN $129,297.00
- Revenue This Year
- AXDX $1.50
- TURN N/A
- Revenue Next Year
- AXDX $4.17
- TURN N/A
- P/E Ratio
- AXDX N/A
- TURN N/A
- Revenue Growth
- AXDX N/A
- TURN 6.32
- 52 Week Low
- AXDX $0.73
- TURN $3.12
- 52 Week High
- AXDX $4.68
- TURN $4.47
- Technical
- Relative Strength Index (RSI)
- AXDX 28.60
- TURN 55.40
- Support Level
- AXDX $1.32
- TURN $3.61
- Resistance Level
- AXDX $1.42
- TURN $3.75
- Average True Range (ATR)
- AXDX 0.12
- TURN 0.11
- MACD
- AXDX -0.04
- TURN -0.01
- Stochastic Oscillator
- AXDX 10.53
- TURN 42.86
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.